- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Champions Oncology Inc (CSBR)
Champions Oncology Inc stock price live, this page displays NASDAQ CSBR stock exchange data. View the CSBR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Champions Oncology Inc real time stock price chart below.
What Is the Champions Oncology Inc Stock Price Today?
The Champions Oncology Inc stock price today is 6.180.
What Is the Stock Symbol for Champions Oncology Inc?
The stock ticker symbol for Champions Oncology Inc is CSBR.
Is CSBR the Same as $CSBR?
$CSBR is a common way to refer to the Champions Oncology Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Champions Oncology Inc Trade On?
Champions Oncology Inc is listed and trades on the NASDAQ stock exchange.
Is Champions Oncology Inc a Good Stock to Buy?
Determining whether Champions Oncology Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Champions Oncology Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CSBR quote. (ISIN: US15870P3073)
What Is the Champions Oncology Inc Stock Price Today?
The Champions Oncology Inc stock price today is 6.180.
What Is the Stock Symbol for Champions Oncology Inc?
The stock ticker symbol for Champions Oncology Inc is CSBR.
Is CSBR the Same as $CSBR?
$CSBR is a common way to refer to the Champions Oncology Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Champions Oncology Inc Trade On?
Champions Oncology Inc is listed and trades on the NASDAQ stock exchange.
Is Champions Oncology Inc a Good Stock to Buy?
Determining whether Champions Oncology Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Champions Oncology Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CSBR quote. (ISIN: US15870P3073)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.740
6.180
52 wk Range
5.500
9.630
CSBR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.7406.180
52 wk Range
5.5009.630
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CSBR Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
12.000
Upside
+94.17%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Operates with a moderate level of debt
- Form 10Q Champions Oncology Inc For: 12 March
- Investing.com
- Form 8K Champions Oncology Inc For: 30 March
- Investing.com
- Form 8K Champions Oncology Inc For: 30 March
- Investing.com
- Champions Oncology appoints Brian Alexander to board
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Champions Oncology Inc Earnings Call Summary for Q3/2026
- Q3 EPS of $0.04 missed forecast of $0.08 by 50%; revenue of $16.6M slightly beat expectations at $16.43M, up 1.03% but down YoY.
- Core study revenue surged 32% YoY to record $16.6M; gross margin fell to 47% from 61% as operating expenses jumped 36% to $7.2M.
- Stock dropped 2.71% to $5.90 in after-hours trading, near 52-week low; shares down 40% over past year despite $12 analyst price target.
- Company plans to bring outsourced radiolabeling in-house to improve margins; expects full-year revenue growth and positive adjusted EBITDA.
- CEO Brainin highlighted PDX bank as key differentiator; projects stronger growth and profitability in fiscal 2027-2028 as customer budgets stabilize.
Last Updated: 03/12/2026, 06:23 PM
Read Full TranscriptCompare CSBR to Peers and Sector
Metrics to compare | CSBR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCSBRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −36.6x | −1.6x | −0.5x | |
PEG Ratio | 0.25 | 0.01 | 0.00 | |
Price / Book | 20.0x | 1.0x | 2.6x | |
Price / LTM Sales | 1.5x | 1.4x | 3.2x | |
Upside (Analyst Target) | 105.4% | 120.3% | 47.6% | |
Fair Value Upside | Unlock | 21.8% | 6.1% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 12.000
(+94.17% Upside)
Earnings
Latest Release
Mar 12, 2026
EPS / Forecast
0.04 / 0.08
Revenue / Forecast
16.6M / 16.43M
People Also Watch
FAQ
What Is the Champions Oncology (CSBR) Stock Price Today?
The Champions Oncology stock price today is 6.180 USD.
What Stock Exchange Does Champions Oncology Trade On?
Champions Oncology is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Champions Oncology?
The stock symbol for Champions Oncology is "CSBR."
What Is the Champions Oncology Market Cap?
As of today, Champions Oncology market cap is 81.130M USD.
What Is Champions Oncology's Earnings Per Share (TTM)?
The Champions Oncology EPS (TTM) is -0.170.
When Is the Next Champions Oncology Earnings Date?
Champions Oncology will release its next earnings report on Jul 16, 2026.
From a Technical Analysis Perspective, Is CSBR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Champions Oncology Stock Split?
Champions Oncology has split 2 times.
How Many Employees Does Champions Oncology Have?
Champions Oncology has 213 employees.
What is the current trading status of Champions Oncology (CSBR)?
As of Apr 16, 2026, Champions Oncology (CSBR) is trading at a price of 6.180 USD, with a previous close of 5.730 USD. The stock has fluctuated within a day range of 5.740 USD to 6.180 USD, while its 52-week range spans from 5.500 USD to 9.630 USD.
What Is Champions Oncology (CSBR) Price Target According to Analysts?
The average 12-month price target for Champions Oncology is 12.000 USD, with a high estimate of 12 USD and a low estimate of 12 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +94.17% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.